Friday, April 18, 2014 Last update: 6:33 PM
Fast Breaking Live News = 100's of Daily Sales Leads

Global miRNA Market Outlook to 2018

Companies mentioned in this article: ReportLinker

NEW YORK, Dec. 24, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global miRNA Market Outlook to 2018

http://www.reportlinker.com/p01929534/Global-miRNA-Market-Outlook-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The report, "Global miRNA Market Outlook to 2018" provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.

The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.

1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques

4.1 miRNA Purification

4.2 miRNA Labeling

4.3 miRNA Linear Amplification

4.4 miRNA Microarrays

4.5 miRNA qRT-PCR

4.6 miRNA Inhibition

5. Global miRNA Market Outlook to 2018

5.1 By Geography

5.1.1 The Americas

5.1.2 Europe

5.1.3 Asia Pacific (APAC)

6. Ongoing miRNA Research by Disease

6.1 Cancer

6.2 Cardiovascular Diseases

6.3 Metabolic Diseases

6.4 Asthma

6.5 Hepatitis

7. Key Players

7.1 Mirna Therapeutics, Inc.

7.2 Rosetta Genomics, Ltd.

7.3 InteRNA Technologies B.V.

7.4 Santaris Pharma A/S

7.5 Regulus Therapeutics

7.6 miRagen Therapeutics

7.7 Qiagen

7.8 Sigma-Aldrich Corporation

7.9 Thermo Fisher Scientific Inc.

7.10 Agilent Technologies Inc.

7.11 Life Technologies Corporation

7.12 System Biosciences

7.13 GeneCopoeia

List of Figures:

Figure 3-1: miRNA Biogenesis

Figure 5-1: Global - miRNA Market (Million US$), 2012-2018

Figure 5-2: Ongoing miRNA Research by Geography (%), 2013

Figure 5-3: The Americas - miRNA Market (Million US$), 2012-2018

Figure 5-4: The Americas - Ongoing miRNA Research by Disease (%), 2013

Figure 5-5: Europe - miRNA Market (Million US$), 2012-2018

Figure 5-6: Europe - Ongoing miRNA Research by Disease (%), 2013

Figure 5-7: Europe - Ongoing miRNA Research by Country (%), 2013

Figure 5-8: APAC - miRNA Market (Million US$), 2012-2018

Figure 5-9: APAC - Ongoing miRNA Research by Disease (%), 2013

Figure 5-10: APAC - Ongoing miRNA Research by Country (%), 2013

Figure 6-1: Ongoing miRNA Research by Disease (%), 2013

Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013

List of Tables:

Table 4-1: miRNA Purification Products by Supplier

Table 4-2: miRNA Labeling Products by Supplier

Table 4-3: miRNA Linear Amplification Products by Supplier

Table 4-4: miRNA Microarray Products by Supplier

Table 4-5: miRNA qRT-PCR Products by Supplier

Table 4-6: miRNA Inhibition Products by Supplier

Table 5-1: The Americas - Ongoing miRNA Research (2013)

Table 5-2: Europe - Ongoing miRNA Research (2013)

Table 5-3: APAC - Ongoing miRNA Research (2013)

Table 6-1: miRNAs associated with Cancer

Table 6-2: miRNA associated with Cardiovascular Diseases

Table 6-3: miRNAs associated with Metabolic Disorders

Table 6-4: miRNAs associated with Hepatitis

Table 7-1: Mirna Therapeutics - miRNA Research Pipeline

Table 7-2: Rosetta Genomics - miRNA based Cancer Tests

Table 7-3: InteRNA - miRNA Research Pipeline

Table 7-4: Santaris Pharma - miRNA Research Pipeline

Table 7-5: Regulus Therapeutics - miRNA Research Pipeline

Table 7-6: miRagen - miRNA Research Pipeline

Table 7-7: Qiagen - miRNA Associated Product Line

Table 7-8: Sigma Aldrich - miRNA Associated Product Line

Table 7-9: Thermo Fisher - miRNA Associated Product Line

Table 7-10: Agilent - miRNA Associated Product Line

Table 7-11: Life Technology - miRNA Associated Product Line

Table 7-12: System Biosciences - miRNA Associated Product Line

Table 7-13: GeneCopoeia - miRNA Associated Product Line

To order this report: Global miRNA Market Outlook to 2018

http://www.reportlinker.com/p01929534/Global-miRNA-Market-Outlook-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker